NATCOPHARM

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
NATCO Pharma Limited

NATCO Pharma Limited (NATCOPHARM) is a Hyderabad, India-headquartered pharmaceutical company, incorporated in 1981, operating in the Healthcare sector as a Specialty & Generic Drug...

₹915.3+0.92%1D
Previous trading day close · Data updates nightly
1W: +0.2%
1M: -5.6%
6M: +8.1%
1Y: -3.1%
79/100
GoodResearch Score
Market Cap
₹16.2K Cr
Mid Cap
P/E Ratio
11.56
Below avg
P/B Ratio
1.78
Reasonable
ROE
16.9%
Decent
ROCE
16.3%
Good
Debt / Equity
0.08
Low debt
Div. Yield
0.7%
Low yield
EV/EBITDA
10.32
Attractive
52W Low: ₹789Current: ₹915.352W High: ₹1,226.8
At 29% of 52-week range
Data as of previous trading day close · Updated nightly
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated nightly
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
85/100
Growth
Revenue, EPS, profit growth
78/100
Valuation
PE, PB, EV/EBITDA vs sector
86/100
Risk
Debt levels, volatility, coverage
80/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
11.56(Below avg)
Forward P/E
19.98(Attractive)
P/B Ratio
1.78(Reasonable)
P/S Ratio
4.02(Good)
EV/EBITDA
10.32(Attractive)
Dividend Yield
0.7%
5Y CAGR
-4.1%(Moderate)
Revenue Growth
-39.6%(Moderate)
Profitability
ROE
16.9%(Good)
ROCE
16.3%(Good)
ROA
7.8%(Average)
Net Margin
34.8%(High)
EBITDA Margin
42.5%
Financial Health
Debt to Equity
0.08(Low debt)
Current Ratio
3.01(Healthy)
Quick Ratio
1.79(Good)
Interest Coverage
41.62x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
48(Neutral)
RSI Exp (14)
38(Neutral)
MACD
-9.581(Bearish)
MACD Signal
-8.357
BB Position
31%(Middle)
BB Width
7.16%(Normal)
ADX (14)
17.1(Sideways)
Williams %R
-73.0(Neutral)
MFI (14)
39(Neutral)
CCI (20)
-81(Neutral)
Stoch %K
27(Neutral)
ATR (14)
18.62(Avg True Range)
OBV (M)
119.4(Positive)
1W OBV Chg
-0.3%(Decreasing)
Rel Volume
0.41x(Low activity)
Volatility
38.8%(Moderate)
Max DD 1Y
-53.1%(High loss)
Alpha (CAPM)
-8.07%(Underperforming)
Return vs Nifty
-2.5%(Below Nifty)
EMA 200
961.5
EMA 50
946.2
SMA 200
944.6
vs SMA 50
-0.3%(Below SMA50)
vs SMA 200
-3.1%(Below SMA200)
Volume
2.70L
Avg Vol 3M
6.6L
Shareholding Pattern
Promoter
49.4%
Moderate
FII
17.4%
DII / MF
5.5%
Share NATCOPHARM
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates nightly after market close. Please consult a SEBI-registered advisor before investing.
NATCOPHARM Share Price - ₹915.30 | Research Score & Analysis | StockSage Pro